Monika Haczkiewicz

Mrs. Monika Haczkiewicz

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2025 in Molecules
Verified
Journal Article
Open access
PDF file
MHMonika Haczkiewicz
Monika Haczkiewicz
MŚMarta Świtalska
Marta Świtalska
Jacek ŁyczkoJacek Łyczko
Jacek Łyczko
MPMagdalena Pluta
Magdalena Pluta
JWJoanna Wietrzyk
Joanna Wietrzyk
Anna GliszczyńskaAnna Gliszczyńska
Anna Gliszczyńska
This study investigated efficient extraction methods for cannabinoids and terpenes from the above-ground parts of Futura 75, focusing on two techniques: pressurized extraction and magnetic stirrer-assisted extraction. The effects of solvent type, temperature, time, and pressure were evaluated using five organic solvents and two binary solvent systems. Cannabinoid profiles of obtained extracts were analyzed using gas chromatography coupled with mass spectrometry (GC-MS), while terpene profiles were characterized through solid-phase microextraction (SPME) combined with GC-MS. Next, two selected extracts with the highest content of cannabinoid and terpene fractions (Futu1 and Futu2) were tested for antiproliferative activity toward cancer cell lines (MV4-11, AGS, HT-29, MDA-MB-468, MCF-7) and their cytotoxicity was evaluated on non-tumorigenic MCF-10A cells. Extract Futu1 contained 51.57% cannabinoids, 9.8% monoterpenes, and 90.2% sesquiterpenes in the terpene fraction. Futu2 exhibited a higher proportion of monoterpenes in the terpene fraction (19.6% monoterpenes and 80.4% sesquiterpenes) and consisted of 49.49% cannabinoids. Both extracts exhibited higher selectivity for cancer cells over non-tumorigenic cells, with Futu2 demonstrating stronger antiproliferative properties. Interestingly, lower concentrations of extracts and tested free, single cannabinoids stimulated the growth of leukemia (MV4-11) and breast cancer (MDA-MB-468) cell lines while their higher concentrations suppressed proliferation.

21 October 2025 in Molecules
Verified
Journal Article
Open access
PDF file
MHMonika Haczkiewicz
Monika Haczkiewicz
MŚMarta Świtalska
Marta Świtalska
Jacek ŁyczkoJacek Łyczko
Jacek Łyczko
JWJoanna Wietrzyk
Joanna Wietrzyk
Anna GliszczyńskaAnna Gliszczyńska
Anna Gliszczyńska
An efficient method for the simultaneous extraction of cannabinoids and terpenes from the leaves and flowers of Cannabis sativa L. (var. Felina 32) was developed. Extraction parameters, including solvent type, temperature, and pressure, were optimized, revealing that hexane enables high-yield cannabinoid recovery. Moreover, terpene composition was influenced by the extraction temperature. Two extracts with the highest cannabinoid content were selected for further study, Feli1 (64.76%) and Feli2 (61.32%), both obtained using hexane. Feli1, extracted at –55 °C, had a monoterpene-to-sesquiterpene ratio of 16.7% to 83.3%, while Feli2, extracted at 25 °C, showed a higher monoterpene content (25.2%) and lower sesquiterpene content (74.8%). Both extracts demonstrated selective antiproliferative activity against cancer cell lines, with reduced toxicity toward normal breast epithelial cells (MCF-10A). Feli2 showed slightly stronger antiproliferative effects, likely due to its higher monoterpene content. At low concentrations, both extracts stimulated the growth of MV4-11 leukemia and MDA-MB-468 triple-negative breast cancer (TNBC) cells, while higher concentrations led to growth inhibition. These stimulatory effects were weaker than those observed for pure Δ9-THC or CBD.

24 September 2026 in Chemical Engineering Journal Advances
Verified
Journal Article
Open access
PRPiotr Rudnicki
Piotr Rudnicki
Daniel BorowiakDaniel Borowiak
Daniel Borowiak
MHMonika Haczkiewicz
Monika Haczkiewicz
JKJerzy Kaleta
Jerzy Kaleta